MENU
+Compare
LFSC
ETF ticker: NASDAQ
AS OF
Sep 4, 03:50 PM (EDT)
Price
$28.43
Change
+$0.41 (+1.46%)

LFSC stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
LFSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for LFSC with price predictions
Sep 03, 2025

Momentum Indicator for LFSC turns positive, indicating new upward trend

LFSC saw its Momentum Indicator move above the 0 level on August 07, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 11 similar instances where the indicator turned positive. In of the 11 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for LFSC just turned positive on August 08, 2025. Looking at past instances where LFSC's MACD turned positive, the stock continued to rise in of 4 cases over the following month. The odds of a continued upward trend are .

LFSC moved above its 50-day moving average on August 07, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LFSC crossed bullishly above the 50-day moving average on August 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFSC advanced for three days, in of 37 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFSC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LFSC broke above its upper Bollinger Band on August 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for LFSC entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Guardant Health (NASDAQ:GH), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Market Cap

The average market capitalization across the F/m Emerald Life Sciences Innovation ETF ETF is 4.84B. The market cap for tickers in the group ranges from 580.57M to 30.13B. INSM holds the highest valuation in this group at 30.13B. The lowest valued company is OFIX at 580.57M.

High and low price notable news

The average weekly price growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was 2%. For the same ETF, the average monthly price growth was 18%, and the average quarterly price growth was 26%. UTHR experienced the highest price growth at 24%, while WVE experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was 60%. For the same stocks of the ETF, the average monthly volume growth was -3% and the average quarterly volume growth was 75%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 69
P/E Growth Rating: 76
Price Growth Rating: 48
SMR Rating: 87
Profit Risk Rating: 74
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
LFSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details